Prospective, single-masked, bilateral wear, cross-over, short-term non-dispensing clinical trial to compare accommodative and binocular function responses between various commercially available and prototype contact lens designs

Brien Holden Vision Institute0 个研究点目标入组 57 人开始时间: 2018年11月1日最近更新: 2019年12月10日

适应症

试验速览

暂无简介。

•Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent.
•Be between 18-40 years old, male or female.
•Willing to comply with the wearing and clinical trial visit schedule as directed by the Investigator.
•Have ocular health findings considered to be normal” and which would not prevent the participant from safely wearing contact lenses.
•Be myopic with less than or equal to 1.00 D of cylindrical power in either eye.
•Be correctable to at least 0.20 logMAR in each eye with single vision contact lenses.

•Any pre-existing ocular irritation, injury or condition (including infection or disease) of the cornea, conjunctiva or eyelids that would preclude contact lens fitting and safe wearing of contact lenses.
•Any systemic disease that adversely affects ocular health e.g. diabetes, Graves disease, and auto-immune diseases such as ankylosing spondylitis, multiple sclerosis, Sjögrens syndrome and systemic lupus erythematosus. Conditions such as systemic hypertension and arthritis do not automatically exclude prospective participants.
•Use of or a need for concurrent category S3 and above ocular medication at enrollment.
•Use of or a need for any systemic medication or topical medications which may alter normal ocular findings / are known to affect a participant’s ocular health / physiology or contact lens performance either in an adverse or beneficial manner at enrolment and/or during the clinical trial.

发起方

Brien Holden Vision Institute